Physician profile
Deborah L Tozer
NPI 1881731040
$1,311.98
in general payments reported to CMS, 2019-2025
24 companies · $21.57 in 2025
The $21.57 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $211 · 2020: $131 · 2021: $444 · 2022: $219 · 2023: $262 · 2024: $23.83 · 2025: $21.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $308.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $307.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $270.96 | 2019-2023 | Lo Loestrin Fe |
| Avion Pharmaceuticals | $165.27 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $116.52 | 2019-2023 | |
| Therapeuticsmd, INC. | $96.39 | 2019-2022 | |
| Organon LLC | $93.47 | 2021-2024 | Nexplanon |
| Myriad Women'S Health, INC. | $60.27 | 2023 | Myrisk |
| Minerva Surgical, INC | $54.21 | 2023 | |
| Coopersurgical, INC. | $52.98 | 2021-2022 | |
| Ethicon US, LLC | $41.15 | 2019-2025 | Vistaseal, Surgicel Nu-Knit |
| Mayne Pharma Commercial LLC | $38.04 | 2021-2022 | |
| Vertical Pharmaceuticals, LLC | $37.56 | 2019-2020 | |
| Exeltis, USA INC. | $35.87 | 2021-2022 | |
| Evofem Biosciences, INC. | $28.26 | 2021-2022 | |
| Roche Diagnostics Corporation | $26.94 | 2020 | |
| Exact Sciences Corporation | $26.40 | 2023 | Cologuard Collection Kit |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $23.63 | 2019 | |
| Meditrina | $21.20 | 2021 | |
| Shield Therapeutics INC | $19.56 | 2023 | Accrufer |
| Astellas Pharma US INC | $18.99 | 2023 | Veozah |
| Pfizer INC. | $18.73 | 2019 | |
| Idorsia Pharmaceuticals US INC | $17.69 | 2023 | Quviviq |
| Daiichi Sankyo INC. | $17.41 | 2019 | |
| Hologic Sales and Service, LLC | $15.45 | 2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $15.03 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deborah Tozer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.